Skip to site content

2023 Update on Hepatitis C Virus (HCV) and Fatty Liver Disease

Quiz for CE Credit

This quiz consists of multiple choice questions with one correct answer.
Please select one answer for each question, then click the Submit Answers button at the end of the quiz.

1. Metabolic Syndrome, including insulin resistance, dyslipidemia and hypertension, are correlated with NASH.

2. The Non-Alcoholic Fatty Liver Disease (NAFLD) spectrum starts are early diagnosis of Non-Alcoholic Steatohepatitis (NASH), progressing into fibrosis and ending with cirrhosis.

3. Non-Alcoholic Steatohepatitis (NASH) is the most common indicator for liver transplantation in women in the United States.

4. Four stages of fibrosis include(s):

5. Metformin is not effective in treating NASH for diabetic nor non-diabetic patients.

6. Weight Management interventions used to manage NAFLD include(s):

7. Hepatitis C is the #1 blood-borne infection and cause of liver cancer in the United States.

8. The medications approved for treatment of Hepatitis C include(s):

9. Hepatitis C has a 95% cure rate after just 12 weeks of treatment.